Hospital
Pella Regional Health Center
Pella Regional Health Center was paid $1.92M by Medicaid between Jan 2018 and Nov 2024, across 53 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.
33Billing provider infoPELLA REGIONAL HEALTH CENTER
PELLA, IA 50219
PELLA, IA 50219
33aNPI1578520888assigned 04/28/2006
33bProvider typeCritical Access Hospital
28Total paid$1.92M
24GClaims58,929
24DCodes billed53
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#15 of 79
Median peer was paid$801K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,870 | $216K | |
| 2019 | 8,922 | $251K | |
| 2020 | 8,334 | $241K | |
| 2021 | 9,178 | $323K | |
| 2022 | 9,278 | $391K | |
| 2023 | 10,921 | $347K | |
| 2024incomplete | 5,426 | $148K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 4,113 | 3,565 | $528K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 1,516 | 1,289 | $344K |
| 80053 | Comprehensive metabolic panel | 14% | 6,809 | 5,863 | $266K |
| 36415 | Collection of venous blood by venipuncture | 9.8% | 26,248 | 21,816 | $189K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.8% | 3,140 | 2,773 | $188K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.8% | 9,341 | 7,920 | $149K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 1,314 | 1,154 | $35K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.4% | 120 | 107 | $26K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 450 | 403 | $25K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.2% | 410 | 364 | $24K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.0% | 703 | 568 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 483 | 442 | $16K |
41 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 315 | $16K |
| 80061 | Lipid panel | <1% | 392 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 487 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 380 | $7K |
| 86140 | <1% | 364 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 86 | $5K |
| 85652 | <1% | 345 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 153 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 182 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 51 | $4K |
| 81001 | <1% | 233 | $3K | |
| 84484 | <1% | 110 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 42 | $2K |
| 81003 | <1% | 208 | $2K | |
| 84703 | <1% | 62 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 15 | $2K |
| 82150 | <1% | 72 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 45 | $1K |
| 83690 | <1% | 91 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 25 | $1K |
| 81015 | <1% | 102 | $1K | |
| 83605 | <1% | 41 | $1K | |
| 87210 | <1% | 65 | $1K | |
| 74019 | <1% | 13 | $960.32 | |
| 87581 | <1% | 15 | $838.88 | |
| 87486 | <1% | 15 | $838.88 | |
| J2704 | Injection, propofol, 10 mg | <1% | 51 | $625.76 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $612.87 |
| 84145 | <1% | 12 | $590.54 | |
| 59025 | Fetal non-stress test | <1% | 20 | $545.31 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 16 | $453.84 |
| 87899 | <1% | 14 | $385.13 | |
| 82947 | <1% | 27 | $356.10 | |
| 85027 | <1% | 14 | $301.19 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 28 | $249.37 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | $205.44 |
| 87428 | <1% | 22 | $204.31 | |
| G0435 | Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening | <1% | 14 | $166.20 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 15 | $118.91 |
| A9270 | Non-covered item or service | <1% | 95 | $95.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $86.94 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKROESE, ROBERT (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Pella Regional Health Center | Ottumwa, IA | $5.31M |
| Pella Regional Health Center | Pella, IA | $3.07M |
| Pella Regional Health Center | Prairie City, IA | $259K |
| Pella Regional Health Center | Sully, IA | $70K |
| Pella Regional Health Center | Pella, IA | $52K |
| Pella Regional Health Center | Ottumwa, IA | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.